Literature DB >> 15158603

Virus inactivation by nucleic acid extraction reagents.

Jamie A Blow1, David J Dohm, Diane L Negley, Christopher N Mores.   

Abstract

Many assume that common methods to extract viral nucleic acids are able to render a sample non-infectious. It may be that inactivation of infectious virus is incomplete during viral nucleic acid extraction methods. Accordingly, two common viral nucleic acid extraction techniques were evaluated for the ability to inactivate high viral titer specimens. In particular, the potential for TRIzol LS Reagent (Invitrogen Corp., Carlsbad, CA) and AVL Buffer (Qiagen, Valencia, CA) were examined to render suspensions of alphaviruses, flaviviruses, filoviruses and a bunyavirus non-infectious to tissue culture assay. The dilution series for both extraction reagents consistently caused cell death through a 100-fold dilution. Except for the DEN subtype 4 positive control, all viruses had titers of at least 10(6)pfu/ml. No plaques were detected in any extraction reagent plus virus combination in this study, therefore, the extraction reagents appeared to inactivate completely each of the high-titer viruses used in this study. These results support the reliance upon either TRIzol LS Reagent or AVL Buffer to render clinical or environmental samples non-infectious, which has implications for the handling and processing of samples under austere field conditions and low level containment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158603     DOI: 10.1016/j.jviromet.2004.03.015

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  55 in total

Review 1.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Evaluation of the inactivation of Venezuelan equine encephalitis virus by several common methods.

Authors:  Edward I Patterson; Kelsey L Warmbrod; Donald H Bouyer; Naomi L Forrester
Journal:  J Virol Methods       Date:  2018-04       Impact factor: 2.014

3.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

4.  Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.

Authors:  Steven Mazur; Michael R Holbrook; Tracey Burdette; Nicole Joselyn; Jason Barr; Daniela Pusl; Laura Bollinger; Linda Coe; Peter B Jahrling; Matthew G Lackemeyer; Jiro Wada; Jens H Kuhn; Krisztina Janosko
Journal:  J Vis Exp       Date:  2016-10-03       Impact factor: 1.355

Review 5.  Diagnosis of Ebola Virus Disease: Past, Present, and Future.

Authors:  M Jana Broadhurst; Tim J G Brooks; Nira R Pollock
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 6.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 7.  Viral Hemorrhagic Fever Diagnostics.

Authors:  Lori D Racsa; Colleen S Kraft; Gene G Olinger; Lisa E Hensley
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

8.  Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests.

Authors:  Maiken Worsøe Rosenstierne; Helen Karlberg; Karoline Bragstad; Gunnel Lindegren; Malin Lundahl Stoltz; Cristiano Salata; Anne-Marte Bakken Kran; Susanne Gjeruldsen Dudman; Ali Mirazimi; Anders Fomsgaard
Journal:  J Clin Microbiol       Date:  2016-07-27       Impact factor: 5.948

9.  Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis.

Authors:  Amie J Eisfeld; Peter J Halfmann; Jason P Wendler; Jennifer E Kyle; Kristin E Burnum-Johnson; Zuleyma Peralta; Tadashi Maemura; Kevin B Walters; Tokiko Watanabe; Satoshi Fukuyama; Makoto Yamashita; Jon M Jacobs; Young-Mo Kim; Cameron P Casey; Kelly G Stratton; Bobbie-Jo M Webb-Robertson; Marina A Gritsenko; Matthew E Monroe; Karl K Weitz; Anil K Shukla; Mingyuan Tian; Gabriele Neumann; Jennifer L Reed; Harm van Bakel; Thomas O Metz; Richard D Smith; Katrina M Waters; Alhaji N'jai; Foday Sahr; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2017-11-16       Impact factor: 21.023

10.  Proficiency of nucleic acid tests for avian influenza viruses, Australasia.

Authors:  Sacha Stelzer-Braid; Ros Escott; Cristina Baleriola; Peter Kirkland; Peter Robertson; Michael Catton; William D Rawlinson
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.